A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection

Overview of attention for article published in Virology Journal, January 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 11,902 followers.

RT @VirologyJ: A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chroni…

30 Jan 2018

Reply Repost Favourite

RT @VirologyJ: A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chroni…

30 Jan 2018

Reply Repost Favourite

A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection https://t.co/WB8yyZWJYV

30 Jan 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.